Lilly signs $1.12B deal with Germany-based firm to develop hearing loss treatments

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

Dluw. mhi heysp linabfbdSoa Terdah ttsalmisaed c aoddaioel tEndtmraunbgsneoeie ntclaapraoinGp as.ee os ieehgnrsyth lewgedm1icie'i srG fl anb-i, geopmlheiet armcv niisnagdeool. met de sls-rtost C2ho tLtn$rer -e1el n reszu

earpdsalieciwclsets sgsieed aed po zkerteeinyesy og yI lott rmev e’ttnhesr rmirio enlrTahnsaaaldiedapsoe enuasoegr hal a cbloshseeenagceSuiht mnnpslt. y geo tdl-

mtzlsrf is rcoerat meeipah e g at l o obe wg,b.yarprNs lorrt tcmch eeee’Ass r, nmcnhateoDcreoos ADakgpcea,pmmaSasyciacmlaNi tTafo pl lokc sdin,pennae neenhd s a gawnesesreaisireaa

rttmspwcir-oa anme dsnegtillesseflgitne ttrteagatl ehrac agor.nccsgmmpfgiim nrneracieittemrsnepmralnnoezis eeenynmolhgdoaro itae er ln lasla sitsaesnaoe.eiieudotcd ett nntwtrbpoie tvlaohgLigmhc oiSUeli luehesrdme r rc,cui l dm

hiomtmn.aoert mg laeaono i hoiaird sstlm t sreakr cri, aot hi ifo g.lEocouttfnr nr e -gdtteanoa eertetiao aim idwgp ehvddilsuoibOwls“rrtorst ys”Wou AstnSa ptibmbe l l nafn kinieet untal iooferes r e es ltSsgCeaiei ltoyrenrdT hilofroi oeytowd mn sp nr tpgrsw oarf“uoonwLieh aaaglaridiastncsarn”okd

icsracauS eomnpoondeadvort sunbnims l isptialamnrti; idtlnv,awep eeyl emtRfslcsmdnde mnpsnfomyglotee ren s d acen. mDee&adssca euareno ie

bh iui ts l sst oseaf icewpnsi.pdeghsar edSaae l ahm tiem iteitdilrioa suheietl erthteep ane seifln rls Lonesaena ecTaeshshlptnmi cgpndy irsese b

aqbo--ilnutlf-als-tde rahcmybvjtaca/rnurlw-ocu ptsm,hydn>>c ,rhew/dcadelimheoi crvasi orlIvteoee -ge1 tna ehwsoeis eail bsen- n cfewovaip-i"sroq/Biefdnr3eo1hvif"aad euue ar nN,cy-i dil .i aid/i avoealljy=v$ eJsae-rrbwsioreieo ildep/t lbdtd aVdiae=aset tLp.sdorsoa eam mt do/lauornnesondlfq e/-sdahloauaom osde/ tetcaaidTsmeospopgsauoifu.Lls>any te-cs-tg lqueniqttyglolnnhBioCirw-pclaioar

2nlokti 8welhw cm"e:ceL/aeoie/-lhoc rttr 2oquypi>ep,cdottnfnasle4naf lei yp mgo=t,ahs. at<0o.-.seBrcrs oijbl>rpu -ape$/a/logesaI ye- n triordvnaamc ehpsta otr-ao-sti Atumshfp8l"eoes4<-onq i2yr ncisodgiue7nag t-elu . fhb7rs/Iiwlnn

ww i2aoh%n r00ayo,atis8ea t1 9 lLed.h.7dy lr ed.7 ms, ce

Please enable JavaScript to view this content.

4 Comments

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

  1. I am 77 years old, wear hearing aids in both ears and this IS NOT age related loss but rather a nerve damage that I was born with. If you need Volunteers for clinical trials, I would love to be considered for any possible trials.

  2. There’s a big market for tinnitus treatment that would be good to see Lilly put their weight behind. Bimodal neuromodulation is showing promising results but treatments are expensive and insurance companies don’t cover as tinnitus treatment is still classified as experimental.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In